{"id":1602,"date":"2019-02-04T09:15:49","date_gmt":"2019-02-04T08:15:49","guid":{"rendered":"http:\/\/www.nanexa.com\/?p=1602"},"modified":"2019-02-05T09:16:17","modified_gmt":"2019-02-05T08:16:17","slug":"nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/","title":{"rendered":"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner"},"content":{"rendered":"<p><strong>Pressmeddelande <\/strong><\/p>\n<p>Uppsala 2019-02-04<\/p>\n<p><strong>Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner<\/strong><\/p>\n<p>Efter fredagens samanr\u00e4kning av antalet tecknade optioner TO1 st\u00e5r det klart att 97,5% av Nanexas teckningsoptioner l\u00f6sts in till aktier. Det motsvarar 22,3 MSEK som nu tillf\u00f6rs Bolaget.<\/p>\n<p>Resultatet kan komma att justeras n\u00e5got efter en final sammanr\u00e4kning. Detta kommer kommuniceras i samband med att emissionen registreras hos Bolagsverket.<\/p>\n<p>&nbsp;<\/p>\n<p>Nanexas VD kommenterar:<\/p>\n<p><em>Det \u00e4r oerh\u00f6rt gl\u00e4djande att s\u00e5 m\u00e5nga valt att teckna aktier med st\u00f6d av teckningsoptionerna TO1. Det ger oss en bra m\u00f6jighet att vidareutveckla bolaget enligt de planer vi satt upp. <\/em><\/p>\n<p>&nbsp;<\/p>\n<p><em>Denna information \u00e4r s\u00e5dan information som Nanexa AB \u00e4r skyldigt att offentligg\u00f6ra enligt EU:s marknadsmissbruksf\u00f6rordning. Informationen l\u00e4mnades, genom ovanst\u00e5ende kontaktpersons f\u00f6rsorg, f\u00f6r offentligg\u00f6rande den 4 februari, 2019.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>F\u00f6r mer information kontakta:<\/p>\n<p>David Westberg \u2013 VD, Nanexa AB (publ)<\/p>\n<p>Telefon: 0709 -42 83 03<\/p>\n<p>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\">david.westberg@nanexa.se<\/a><\/p>\n<p>www.nanexa.com<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>&nbsp;<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug deliveryf\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<sup>\u00ae<\/sup>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<sup>\u00ae<\/sup>har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pressmeddelande <\/p>\n<p>Uppsala 2019-02-04<\/p>\n<p>Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner<\/p>\n<p>Efter fredagens samanr\u00e4kning av antalet tecknade optioner TO1 st\u00e5r det klart att 97,5% av Nanexas teckningsoptioner l\u00f6sts in till aktier.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1602","post","type-post","status-publish","format-standard","hentry","category-pressmeddelanden"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Pressmeddelande Uppsala 2019-02-04 Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner Efter fredagens samanr\u00e4kning av antalet tecknade optioner TO1 st\u00e5r det klart att 97,5% av Nanexas teckningsoptioner l\u00f6sts in till aktier.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-04T08:15:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-05T08:16:17+00:00\" \/>\n<meta name=\"author\" content=\"Anders Johansson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders Johansson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\\\/\"},\"author\":{\"name\":\"Anders Johansson\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\"},\"headline\":\"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner\",\"datePublished\":\"2019-02-04T08:15:49+00:00\",\"dateModified\":\"2019-02-05T08:16:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\\\/\"},\"wordCount\":228,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Pressmeddelanden\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\\\/\",\"name\":\"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2019-02-04T08:15:49+00:00\",\"dateModified\":\"2019-02-05T08:16:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/d26735c022a71d41737953c23a07692a\",\"name\":\"Anders Johansson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g\",\"caption\":\"Anders Johansson\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/anders\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner - Nanexa AB","og_description":"Pressmeddelande Uppsala 2019-02-04 Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner Efter fredagens samanr\u00e4kning av antalet tecknade optioner TO1 st\u00e5r det klart att 97,5% av Nanexas teckningsoptioner l\u00f6sts in till aktier.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/","og_site_name":"Nanexa AB","article_published_time":"2019-02-04T08:15:49+00:00","article_modified_time":"2019-02-05T08:16:17+00:00","author":"Anders Johansson","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"Anders Johansson","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/"},"author":{"name":"Anders Johansson","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a"},"headline":"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner","datePublished":"2019-02-04T08:15:49+00:00","dateModified":"2019-02-05T08:16:17+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/"},"wordCount":228,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Pressmeddelanden"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/","url":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/","name":"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2019-02-04T08:15:49+00:00","dateModified":"2019-02-05T08:16:17+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-tillfors-223-msek-fran-inlosen-av-teckningsoptioner\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa tillf\u00f6rs 22,3 MSEK fr\u00e5n inl\u00f6sen av teckningsoptioner"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/d26735c022a71d41737953c23a07692a","name":"Anders Johansson","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1eee3bf26eba126e14bce6671b99389c3e366b0577f9fa176d41797d92204ff1?s=96&d=mm&r=g","caption":"Anders Johansson"},"url":"https:\/\/nanexa.com\/sv\/author\/anders\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=1602"}],"version-history":[{"count":2,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1602\/revisions"}],"predecessor-version":[{"id":1604,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/1602\/revisions\/1604"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=1602"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=1602"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=1602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}